Cargando…
Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
BACKGROUND: Temozolomide (TMZ) treatment efficacy in glioblastoma (GBM) patients has been limited by resistance in the clinic. Currently, there are no clinically proven therapeutic options available to restore TMZ treatment sensitivity. Here, we investigated the potential of albumin-bound paclitaxel...
Autores principales: | Qu, Shanqiang, Qi, Songtao, Zhang, Huayang, Li, Zhiyong, Wang, Kaicheng, Zhu, Taichen, Ye, Rongxu, Zhang, Wanghao, Huang, Guanglong, Yi, Guo-zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612313/ https://www.ncbi.nlm.nih.gov/pubmed/37891669 http://dx.doi.org/10.1186/s13046-023-02843-6 |
Ejemplares similares
-
Correction: albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
por: Qu, Shanqiang, et al.
Publicado: (2023) -
Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder
por: Wang, Luyao, et al.
Publicado: (2023) -
Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
por: Tian, Zhichao, et al.
Publicado: (2022) -
The Ependymal Region Prevents Glioblastoma From Penetrating Into the Ventricle via a Nonmechanical Force
por: Li, Kaishu, et al.
Publicado: (2021) -
Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
por: Hassan, Md Sazzad, et al.
Publicado: (2018)